npj Genomic Medicine

Scope & Guideline

Connecting Laboratory Insights to Patient Care

Introduction

Welcome to the npj Genomic Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of npj Genomic Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN-
PublisherNATURE PORTFOLIO
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationNPJ GENOM MED / npj Genom. Med.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressHEIDELBERGER PLATZ 3, BERLIN 14197, GERMANY

Aims and Scopes

The journal 'npj Genomic Medicine' focuses on the intersection of genomics and medicine, emphasizing the application of genomic insights to clinical care and the understanding of genetic diseases. It aims to foster research that bridges the gap between genomic discoveries and their practical implications in medicine.
  1. Clinical Genomics and Personalized Medicine:
    The journal prioritizes research that utilizes genomic data to tailor medical treatments to individual patients, particularly in the context of rare genetic disorders and complex diseases.
  2. Genomic Technologies and Methodologies:
    A strong emphasis is placed on innovative genomic technologies, including sequencing techniques, bioinformatics, and data analysis methods that enhance the understanding of genetic variations and their implications.
  3. Population Genetics and Ethnic Diversity:
    Research exploring genetic diversity across different populations is a core area, highlighting the significance of ethnic backgrounds in genetic predisposition to diseases and responses to treatments.
  4. Integration of Genomics in Clinical Practice:
    The journal aims to report on the integration of genomic data into clinical workflows, including diagnostic applications, therapeutic strategies, and the ethical considerations surrounding genomic medicine.
  5. Disease Mechanisms and Genetic Contributions:
    Investigations into the genetic underpinnings of various diseases, including cancer, neurodevelopmental disorders, and cardiovascular conditions, are a significant focus, elucidating how genetic factors influence disease pathology.
Recent publications indicate several emerging themes that are gaining traction within 'npj Genomic Medicine', reflecting the journal's responsiveness to advancements in genomic technologies and clinical applications.
  1. Polygenic Risk Scores and Predictive Genomics:
    There is an increasing emphasis on polygenic risk scores as tools for predicting disease susceptibility and outcomes, showcasing their potential in personalized medicine and preventive healthcare.
  2. Integration of Multi-Omics Approaches:
    Emerging studies are increasingly adopting multi-omics strategies, integrating genomics with transcriptomics, proteomics, and metabolomics to provide a comprehensive understanding of disease mechanisms.
  3. Ethics and Inclusivity in Genomic Medicine:
    The journal is seeing a growing interest in the ethical implications of genomic research, particularly regarding inclusivity and representation in genetic studies, ensuring diverse populations are adequately represented.
  4. Real-World Applications of Genomic Data:
    Research is trending towards practical applications of genomic data in clinical settings, including the implementation of rapid genomic sequencing in urgent care scenarios and its impact on patient management.
  5. Advancements in Gene Editing Technologies:
    There is a surge in research focusing on gene editing technologies, such as CRISPR, and their potential therapeutic applications, indicating a shift towards innovative treatment strategies for genetic disorders.

Declining or Waning

While 'npj Genomic Medicine' continues to advance in various areas, certain themes have shown a decline in prominence over recent years. These waning scopes reflect changing research priorities and advancements in technology and understanding.
  1. Basic Genetic Research:
    Research focused solely on basic genetic mechanisms without direct clinical implications appears to be declining, as the journal emphasizes translational research that connects genetic findings to medical applications.
  2. Single-Disease Focus Studies:
    There is a noticeable decrease in studies that focus exclusively on single genetic disorders. Instead, the journal is increasingly featuring multi-disease approaches and integrative studies that consider the genetic basis of multiple conditions.
  3. Traditional Genetic Testing Approaches:
    With the advent of more sophisticated genomic sequencing technologies, traditional genetic testing methods are becoming less common in published research, as newer methods offer greater accuracy and broader insights.
  4. General Population Studies:
    The focus on broad population studies without specific clinical relevance is waning, with a shift towards studies that provide actionable insights for clinical practice and patient care.

Similar Journals

PLoS Genetics

Driving discoveries in genetics for a healthier tomorrow.
Publisher: PUBLIC LIBRARY SCIENCEISSN: 1553-7404Frequency: 12 issues/year

PLoS Genetics, published by the PUBLIC LIBRARY SCIENCE, is a leading open-access journal dedicated to advancing the field of genetics, molecular biology, and related disciplines. With its ISSN of 1553-7404, this esteemed journal has been offering unrestricted access to its content since 2005, fostering a global community of researchers, professionals, and students. Situated in the United States, its contributions can be found at 1160 Battery Street, Ste 100, San Francisco, CA 94111. As of 2023, PLoS Genetics proudly holds a Q1 ranking in multiple categories including Cancer Research, Ecology, Evolution, Behavior and Systematics, Genetics, and Molecular Biology, underscoring its impact in these vital scientific areas. The journal's commitment to disseminating high-quality research is reflected in its impressive Scopus rankings, with notable positions in various fields of study, ensuring that it remains a crucial resource for cutting-edge research and innovation. By providing an open-access platform, PLoS Genetics not only enhances the visibility of genetic research but also encourages collaborations and the sharing of knowledge that can lead to significant breakthroughs in science.

Frontiers in Genetics

Innovative Research, Global Impact
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Genetics is a premier academic journal dedicated to advancing the field of genetics through high-quality, peer-reviewed research. Published by FRONTIERS MEDIA SA in Switzerland since 2010, this Open Access journal provides a platform for researchers and practitioners to disseminate innovative findings across various subfields, including clinical genetics and molecular medicine. With a notable emphasis on interdisciplinary approaches, the journal holds a strong position in the academic landscape, achieving Q2 rankings in key categories such as Genetics and Molecular Medicine in 2023. Not only does Frontiers in Genetics contribute to the scholarly dialogue by publishing impactful studies, but it also promotes accessibility to vital research, ensuring that knowledge is available to a global audience. This journal is a vital resource for researchers, professionals, and students looking to stay at the forefront of genetic discoveries and their applications, reflective of its engagement with contemporary challenges in genetics and healthcare.

Human Genomics

Pioneering Discoveries in Genomics and Medicine
Publisher: BMCISSN: 1473-9542Frequency: 1 issue/year

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

Global Medical Genetics

Pioneering Research for a Genetic Revolution
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

EUROPEAN JOURNAL OF HUMAN GENETICS

Advancing the Frontiers of Human Genetics
Publisher: SPRINGERNATUREISSN: 1018-4813Frequency: 12 issues/year

The EUROPEAN JOURNAL OF HUMAN GENETICS, published by SpringerNature, stands as a preeminent platform in the field of genetics and clinical genetics. Established in 1993, this prestigious journal, with an ISSN of 1018-4813 and an E-ISSN of 1476-5438, has consistently maintained its position in the Q1 quartile for both Genetics and Clinical Genetics categories as of 2023, reflecting its significant contributions to the field. Its impact is further underscored by its impressive Scopus rankings, placing it in the 92nd percentile among clinical genetics journals. The journal aims to disseminate cutting-edge research, case studies, and reviews that advance our understanding of human genetics, promoting collaboration and innovation among researchers, professionals, and students alike. While it does not currently offer open access, the journal provides substantial value through its rigorous peer review process and commitment to quality. As it continues to shape the future of genetic research through 2024 and beyond, the EUROPEAN JOURNAL OF HUMAN GENETICS remains an essential resource for those dedicated to exploring the complexities of human heredity.

International Journal of Genomics

Exploring the frontiers of genetics and molecular biology.
Publisher: HINDAWI LTDISSN: 2314-436XFrequency: 1 issue/year

International Journal of Genomics is a pivotal open-access publication under the esteemed HINDAWI LTD, dedicated to advancing the fields of genomics, biochemistry, genetics, and molecular biology. Established in 2013, this journal aims to disseminate innovative research findings and foster scholarly dialogue among researchers, professionals, and students alike. With a robust Impact Factor reflective of its commitment to quality, the journal has achieved a Q3 ranking in Biochemistry, Genetics, and Molecular Biology, as well as notable placements in Pharmaceutical Science, indicating its broad relevance and influence in these interconnected fields. The journal is indexed in esteemed databases, ensuring high visibility and accessibility for published works. As an open-access journal, it prioritizes the sharing of knowledge across borders, facilitating greater collaboration and advancement in genomic research globally. Join the academic community in exploring the vast potential of genomics through the International Journal of Genomics, based in Egypt, and reaching audiences worldwide from its London office.

HUMAN GENETICS

Pioneering insights into human health and disease.
Publisher: SPRINGERISSN: 0340-6717Frequency: 12 issues/year

HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.

Genetics Research

Advancing Knowledge in Genetics and Molecular Biology
Publisher: HINDAWI LTDISSN: 0016-6723Frequency: 1 issue/year

Genetics Research, published by HINDAWI LTD, is a distinguished open access journal that has been at the forefront of genetic studies since its inception in 1960. With the transition to open access in 2019, this journal has expanded its accessibility, fostering knowledge dissemination across the global scientific community. Operating out of the United Kingdom, it provides a platform for innovative research in the fields of genetics and molecular biology, encompassing a broad range of topics that are highly relevant to medical sciences. As of 2023, it holds a Q4 classification in Genetics and a Q3 classification in miscellaneous Medicine, reflecting its ongoing commitment to scholarly excellence amidst shifting academic landscapes. While the journal's H-index remains unlisted, its indexed ranking within Scopus, with a rank of #325/328 in the Genetics category highlights the challenges ligated to its niche audience. Nevertheless, it serves as a crucial resource for researchers, professionals, and students eager to contribute to and stay informed on the latest genetic research trends and breakthroughs.

Molecular Genetics & Genomic Medicine

Advancing the frontiers of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.

Evolutionary Bioinformatics

Innovating the intersection of biology and computation.
Publisher: SAGE PUBLICATIONS LTDISSN: 1176-9343Frequency: 4 issues/year

Evolutionary Bioinformatics, published by SAGE Publications Ltd, is a pioneering open-access journal established in 2005, dedicated to advancing the field of evolutionary biology through innovative computational techniques and bioinformatics. With an ISSN of 1176-9343, it serves as a critical platform for researchers, professionals, and students to disseminate impactful findings and foster collaboration across disciplines. The journal spans a broad scope, contributing significantly to the areas of Ecology, Evolution, Behavior and Systematics, and Genetics, as evidenced by its respectable Scopus rankings and quartile placements in 2023. With a commitment to providing comprehensive, peer-reviewed research articles and tools for sharing knowledge, Evolutionary Bioinformatics plays an essential role in shaping the future of evolutionary studies and bioinformatics. Readers and contributors alike are encouraged to engage with cutting-edge research that pushes the boundaries of understanding in this dynamic field.